Correlation Between Lipocine and CalciMedica, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lipocine and CalciMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and CalciMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipocine and CalciMedica, Common Stock, you can compare the effects of market volatilities on Lipocine and CalciMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of CalciMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and CalciMedica, Common.

Diversification Opportunities for Lipocine and CalciMedica, Common

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Lipocine and CalciMedica, is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and CalciMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CalciMedica, Common Stock and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with CalciMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CalciMedica, Common Stock has no effect on the direction of Lipocine i.e., Lipocine and CalciMedica, Common go up and down completely randomly.

Pair Corralation between Lipocine and CalciMedica, Common

Given the investment horizon of 90 days Lipocine is expected to generate 1.5 times more return on investment than CalciMedica, Common. However, Lipocine is 1.5 times more volatile than CalciMedica, Common Stock. It trades about 0.02 of its potential returns per unit of risk. CalciMedica, Common Stock is currently generating about -0.28 per unit of risk. If you would invest  476.00  in Lipocine on September 20, 2024 and sell it today you would lose (2.00) from holding Lipocine or give up 0.42% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lipocine  vs.  CalciMedica, Common Stock

 Performance 
       Timeline  
Lipocine 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, Lipocine is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
CalciMedica, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CalciMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Lipocine and CalciMedica, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lipocine and CalciMedica, Common

The main advantage of trading using opposite Lipocine and CalciMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, CalciMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CalciMedica, Common will offset losses from the drop in CalciMedica, Common's long position.
The idea behind Lipocine and CalciMedica, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Directory
Find actively traded commodities issued by global exchanges